Economic evaluation is becoming an increasingly important part of the evaluation of health and mental health services. Current models for conducting economic evaluation, including cost-effectiveness analysis, cost-benefit analysis, and cost-utility analysis, have great potential for improving the quality of decision-making and for making mental health programs more effective and efficient. This paper presents the basic economic theory underlying the various forms of economic evaluation and provides general guidelines for developing and conducting an economic analysis of a health program.
T oday's psychiatric administrator is expected to be familiar with the concepts of "economic evaluation," in order to ensure that value is received for money spent. This paper seeks to demystify cost-benefit and costeffectiveness analyses so that their real uses can be recognized, and the places in which the jargon of economic analysis is used inappropriately can be spotted.
Few of the many papers (both theoretical and empirical) on the subject of economic evaluation in the health care field deal directly with Canadian mental health issues. Most of the theoretical papers deal with the health care field in general, while most of the empirical studies were conducted in the United States, whose health care system is very different from that in Canada.
In this paper, we try to draw out the aspects of economic evaluation which could be applied to mental health care in Canada. First, we briefly present the theory underlying economic evaluations; more detail can be obtained from the general references at the end of the article. Next, we describe various types of economic evaluations and when each approach is appropriate. Theoretical problems are outlined next, followed by a series of guidelines for developing and Can. J. Psychiatry Vol. 34, October 1989 633 conducting economic analysis. In a follow-up article, the application of economic analysis to mental health services is discussed in more detail.
The Theory Behind Economic Evaluation: The Basics
The purpose of an economic evaluation is to compare alternatives in terms oftheir costs and consequences (1 -4) , and select the one which gives the highest expected value. The techniques can in theory be used for a wide variety of problems-from determining whether or not to build a dam, to selecting the most appropriate treatment for a particular disability (for example, inpatient versus outpatient treatment for schizophrenic patients, or long-term versus short-term intensive therapy for depressed patients).
Despite its name, an "economic" evaluation does not deal solely with costs; it can instead be seen as analogous to "value for money" accounting. The methodological difficulties thus revolve around deciding which costs and consequences should be included, and how they are to be measured.
A "cost," as used in economics, is not restricted to the dollars spent on a service; it also includes the sacrifice of the resources which could have been used for alternative purposes ("opportunity costs"). This expansive definition is rarely used in practice. Even restricting the computation to the costs of a treatment program requires one to put dollar values on a wide variety of goods and services, including: staff time, facilities' capital and operating expenses (including buildings and land), supplies and equipment, patient and family time, inconvenience and discomfort, social benefits, and even such indirect social costs as changes in property values that may result when part of a city becomes a "psychiatric ghetto." Thus, in a full economic evaluation a comparison to other programs is necessary, because all of these resources could have been used for "something else" which might have produced a greater net benefit.
Economic evaluations typically use dollar values because they are the common language of exchange. However, dollar values must often be modified if they do not reflect true costs. For example, an agency may not have to pay rent for its accomodation in a government building, but the building does have a "cost," and the space could have been used for other purposes. Analysts often attempt to estimate what rent third parties would be willing to pay, and "impute"~cost. Sim~ larly, "free" services which are provided to patients by their relatives are often given imputed costs (for example, valuing Vol. 34, No.7 their time by mulitplying hours spent by some reasonable pay rate, to take into consideration the alternative activities which they have foregone.)
To account for the fact that a dollar in the future is worth less than a dollar today, most analysts "discount" costs and benefits which will occur in the future, and compute a "net present value."
Consequences of treatments are also defined broadly in economic evaluations. Consequences can be positive or negative, as well as expected or unexpected. In an economic evaluation, one tries to measure not only clinical effectiveness (changes in physical, social, and emotional functioning), but also changes in the use of health and social services, and changes in the use of "services" provided by the patient's family (i.e. of those items mentioned earlier in the list of costs). Depending on the analysis, such items can be entered either as negative costs (i.e. on the cost side of the equation), or as positive benefits.
Distinguishing Between the Types of Economic Evaluation
There is often confusion over the various types of economic evaluations, and the nature of their differences. In this section, we describe the major types of economic evaluation and summarize the key characteristics of each type.
Cost-benefit analyses attempt to measure all of the costs and consequences associated with a given program or service in dollar terms. Cost-benefit studies are the purest form of economic analysis (adhering most closely to the economic definitions of costs and alternatives), and were the earliest to be used in analyses of public services. The analyst can then compute the ratio of costs to benefits (termed the costbenefit ratio). Because "all" costs and benefits are measured (in practical terms, this means as many as possible), and because dollar values act as a common unit, in theory, very different programs can be compared using cost-benefit analysis.
When benefits are easily measured in dollars (for example, investment decisions), cost-benefit analysis is fairly straightforward. However, in health care, benefits are usually measured by changes in mortality and morbidity. Efforts to convert such benefits into dollar terms are usually forced and unsatisfactory. For example, valuing human lives in terms of the expected future earnings assumes that the elderly or unemployed have zero (or negative) value, and that the very young (because the effect of compound interest means that discounted future earnings are worth relatively little) have little value to society. Alternative approaches (for example, using the values paid by life insurance companies) are equally problematic. Accordingly, most reputable analysts have abandoned cost-benefit in favour of cost-effectivenessor costutility analysis. (However, see reference 5 for one excellent attempt in the mental health care field, which is discussed in more detail in Part II of this series.)
Cost-effectiveness analysis insists that each of costs and benefits be measured in a single unit, but allows the benefits to be computed in non-dollar terms. The most common effectiveness unit is the "life year." If morbidity is a greater concern than mortality, one could use such measures as "symptom-free years," number of days without alcohol, or decreased antisocial or maladaptive behaviour as defined by some test or observation method. The important matter is that all relevant consequences must be measurable in the chosen unit. A cost-effectiveness ratio is then calculated (costs per outcome unit) which indicates how many resources had to be expended to achieve one unit of outcome. This ratio can then be used to compare alternative programs with similar objectives.
Cost-utility analysis further modifies the measurement of outcome to reflect the fact that not all life years are created equal; a patient would presumably prefer to spend time being healthy and ambulatory rather than comatose or bedridden. A cost-utility analysis thus adjusts the benefits to account for the quality of life; benefits are commonly measured in Quality-AdjustedLife Years, or QALYs (6) . The art of measuring the utility, or satisfaction, derived by the patient from a clinical outcome is an active (and difficult) research area, commonly known as "multi-attribute utility estimation." As a simplifying measure, health status indices are often used to derive these measures, with weights assigned to particular health conditions from surveys or patient interviews. Point of view is again important, since the valuation of a particular health state by healthy respondents may be quite different to the views of patients in that condition (6) .
Cost-minimization studies are abbreviated costeffectiveness analyses. They are performed when it is known that two programs would yield essentially the same outcomes (see, for example, references 7 and 8, which are discussed in more detail in Part II of this series). If one knows that consequences are equal, it follows that one can compare costs across programs and pick the least expensive. A costminimization study would be appropriate, for example, once a clinical trial had established the equivalency of two treatment protocols.
Theoretical Issues
Which costs and consequences should be included is often controversial. For example, cost-effectiveness analysis usually measures only those costs and consequences directly associated with treatment. These usually include clinical outcomes, direct agency costs (sometimes limited to treatment from one agency, and other times including treatment from other agencies), and occasionally patient earnings foregone or restored by treatment. It would not include questions like the impact of productivity gains or losses on the national economy, or the alternative ways the resources could have been used. A common but inaccurate practice is to include those costs which can easily be computed, and to omit the (often crucial) "intangibles."
Another important consideration in economic evaluations is the question of point of view. The broadest perspective, and the one closest to economic theory, is that of society, where all costs and consequences are theoretically taken into consideration. From a societal perspective, a program should be implemented only if its overall effect on the whole of society is more positive than the next best alternative. Other viewpoints, in descending order of scope, are the viewpoint of the entire health and social service sector, the provincial or federal government, a Ministry or Department within government, an individual organization, and finally, the viewpoint of one individual, (for example, the clinician or patient). Although early economic evaluations in health care were conducted from the perspective of society, costeffectiveness analysis has increasingly also been linked to medical decision-making models in order to examine treatment alternatives from the viewpoint of the patient. It is important to recognize that the viewpoint used has implications for which costs and outcomes are measured, and for how they are measured. As one example, certain costs (travel, waiting time, discomfort) may be important to the patient, but not to the health facility. As another, the gains or losses to society may be quite different from the impact on a patient or on a provider. When reading or performing an economic evaluation, it is therefore important to inquire into the perspective taken and the accompanying assumptions about costs and benefits, since computed cost-effectiveness or cost-utility ratios may vary widely, depending on whose costs and consequences are taken into account.
Implicit in the cost-effectivenessand cost-utility approaches is the necessity of comparing two or more alternatives. Only a cost-benefit analysis enables us to say whether a particular intervention will produce benefits which exceed their costs. Moving from the simple world of measuring everything in dollars instead requires us to say whether achieving a particular health benefit (for example, an extending life by a given number of QALYs) is "worth" the money expended. In the absence of an agreed-upon value for a human life, one must instead fall back on a comparative argument: "For an equivalent expenditure, program A would provide a greater number of our effectiveness units than would program B, and should therefore have priority for available funds."
In practical terms, an analyst or administrator will often look only at one particular program, and compute a costeffectiveness ratio. Such analyses are more appropriately labeled "cost-outcome studies, " since no direct comparison to other programs is made. In general, just as clinical trials require a control group, an economic evaluation of a program or service requires a comparison group.
Although most economic evaluations reflect the reality that resource allocation choices and decisions are usually related to programs which perform a similar function (for example, which of a set of alcohol treatment programs will achieve the most "bang for the buck"), in theory, economic evaluations could be used to compare very different programs with different purposes, as long as it were possible to express all costs in dollars, and all consequences in some constant measure (9) .
How To Do an Economic Evaluation
Since economic evaluations are essentially effectiveness (or program) evaluations with an added costing component, and usually take a wider viewpoint, the steps involved in performing a cost-benefit or cost-effectiveness analysis are similar to those in any evaluation. 1. The alternative programs or interventions are defined. This usually includes the target group, the manner in which the program functions, and the quantifiable or observable changes in behaviour. 2. The expected outcomes of each program are identified. 3 . Probability values are attached to each outcome. (For example, for a given intervention, what is the probability that the patient will be: improved, the same, worse?). These probability values are usually based on data bases or similar epidemiological studies, although in the absence of better information, the consensus of experts may be used. 4. For each program, the cost (i.e. value of the resources consumed) is computed. 5. The value of each potential outcome is quantified, either as a dollar value, an effectiveness measure, or a "utility" measure (depending on the type of analysis). 6. A decision rule is selected. In most economic evaluations, the optimum choice is considered to be the one which would yield the highest' 'expected value," although this may have to be modified in situations where one of the alternatives is considered highly risky (10). 7. If maximizing expected value is selected as the decision rule, the "expected value" of each intervention is computed by multiplying the probability of each outcome by its value, and summing the results. 8. A comparison of the results for the programs of interest is performed (11) and one option recommended.
A noted above, the computations may be difficult, and it may be necessary to estimate certain aspects of costs or benefits. Among the strengths of these techniques are the concepts of "sensitivity analysis" and "threshold analysis," which allow the analyst to vary systematically the values assigned to certain factors (for example, probability of treatment success; costs of drugs) and see what if any difference such changes make to the policy recommendations (12) . A threshold analysis, for example, allows one to compute the value a particular factor would have to take on in order to change which program would be recommended; in many cases, it becomes evident that, although the true value is indeed uncertain, the recommendation would remain unchanged over the full range of reasonable alternatives. Sensitivity and threshold analysis thus provides a powerful tool by which analysts can see how robust their conclusions are, and identify which variables could affect their recommendations (and hence, where future data gathering efforts should be concentrated).
Conclusions
In this paper we have described the essential theoretical and measurement concepts involved in conducting economic evaluations, as well as the applicability and usefulness of a variety of analytic methods. In Part II of this series, we apply these concepts to the mental health field specifically, and 
